Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Rebold
Thomas Lodise
Michael J Rybak

Showing results (1-10 of 356) with videos related to

Pageof 36
Sort By:
Pharmacotherapy|February 2, 2023
Oral stepdown in Gram-positive bloodstream infections: A step in the right directionKaylee E Caniff, Nicholas Rebold, Michael J Rybak
Infectious Diseases and Therapy|February 12, 2022
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosaAshlan J Kunz Coyne, Amer El Ghali, Dana Holger, et al.
Open Forum Infectious Diseases|March 27, 2023
High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase ProductionAshlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 5, 2024
Antibiotic stewardship in the emergency department setting: Focus on oral antibiotic selection for adults with skin and soft tissue infectionsHeather M Draper, Michael J Rybak, Kerry L LaPlante, et al.
American Health & Drug Benefits|August 21, 2019
Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from Decision-Analytic ModelsThomas Lodise, Kenneth LaPensee
American Health & Drug Benefits|February 13, 2019
Potential Cost-Savings with Once-Daily Aminomethylcycline Antibiotic versus Vancomycin in Hospitalized Patients with Acute Bacterial Skin and Skin Structure InfectionsKen LaPensee, Thomas Lodise
The American Journal of Medicine|June 1, 2006
Pharmacodynamics: relation to antimicrobial resistanceMichael J Rybak
The Annals of Pharmacotherapy|July 1, 2004
Increased bacterial resistance: PROTEKT US--an updateMichael J Rybak
American Journal of Infection Control|July 4, 2006
Pharmacodynamics: relation to antimicrobial resistanceMichael J Rybak
Pharmacotherapy|December 9, 2004
Resistance to antimicrobial agents: an updateMichael J Rybak
Pageof 36

Showing results (1-10 of 356) with videos related to

Sort By:
Pageof 36
Pharmacotherapy|February 2, 2023
Oral stepdown in Gram-positive bloodstream infections: A step in the right directionKaylee E Caniff, Nicholas Rebold, Michael J Rybak
Infectious Diseases and Therapy|February 12, 2022
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosaAshlan J Kunz Coyne, Amer El Ghali, Dana Holger, et al.
Open Forum Infectious Diseases|March 27, 2023
High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase ProductionAshlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 5, 2024
Antibiotic stewardship in the emergency department setting: Focus on oral antibiotic selection for adults with skin and soft tissue infectionsHeather M Draper, Michael J Rybak, Kerry L LaPlante, et al.
American Health & Drug Benefits|August 21, 2019
Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from Decision-Analytic ModelsThomas Lodise, Kenneth LaPensee
American Health & Drug Benefits|February 13, 2019
Potential Cost-Savings with Once-Daily Aminomethylcycline Antibiotic versus Vancomycin in Hospitalized Patients with Acute Bacterial Skin and Skin Structure InfectionsKen LaPensee, Thomas Lodise
The American Journal of Medicine|June 1, 2006
Pharmacodynamics: relation to antimicrobial resistanceMichael J Rybak
The Annals of Pharmacotherapy|July 1, 2004
Increased bacterial resistance: PROTEKT US--an updateMichael J Rybak
American Journal of Infection Control|July 4, 2006
Pharmacodynamics: relation to antimicrobial resistanceMichael J Rybak
Pharmacotherapy|December 9, 2004
Resistance to antimicrobial agents: an updateMichael J Rybak
Pageof 36